The cost effectiveness of antiretroviral treatment strategies in resource-limited settings

AIDS

Volumn 21, Issue 10, 2007, Pages 1333-1340

  Bishai, David ^a   Colchero, Arantxa ^a   Durack, David T ^b,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b BD Technologies   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

AIDS; Antiretroviral treatment; CD4 lymphocytes; Cost effectiveness; Developing countries; HIV; Laboratory testing; Resource limited settings; Viral load

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; LAMIVUDINE; ZIDOVUDINE;

ARTICLE; CD4+ T LYMPHOCYTE; COST EFFECTIVENESS ANALYSIS; DRUG COST; FOLLOW UP; HEALTH CARE COST; HOSPITAL CHARGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LYMPHOCYTE COUNT; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RESOURCE ALLOCATION; TREATMENT OUTCOME; VIRUS LOAD;

ALGORITHMS; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; HEALTH CARE COSTS; HIV INFECTIONS; HUMANS; LYMPHOCYTE COUNT; QUALITY-ADJUSTED LIFE YEARS; VIRAL LOAD;

EID: 34249992820     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328137709e     Document Type: Article

References (21)

1. World Health Organization. Scaling Up Antiretroviral Therapy in Resource-Limited Settings: Guidelines for a Public Health Approach. Geneva: World Health Organization; 2002.
2. World Health Organization. Scaling Up Antiretroviral Therapy in Resource-Limited Settings: Treatment Guidelines for a Public Health Approach, 2003 Revision. Geneva: World Health Organization; 2004.
3. Gutierrez JP, Johns B, Adam T, Bertozzi SM, Edejer TT, Greener R, et al. Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost? Lancet 2004; 364:63-64.
4. Bishai D, Colchero A. Hopkins Population Center Working Paper Series: Technical Appendix to the Microsimulated AIDS Costs and Outcomes (MACO) Model. Baltimore, MD: Hopkins Population Center; 2007. http://www.jhsph.edu/ popcenter/publications/workpapers.
5. Taylor JM, Tan SJ, Detels R, Giorgi JV. Applications of a computer simulation model of the natural history of CD4 T-cell number in HIV-infected individuals. AIDS 1991; 5:159-167.
6. Taylor JM, Law N. Does the covariance structure matter in longitudinal modelling for the prediction of future CD4 counts? Stat Med 1998; 17:2381-2394.
7. Taylor JM, Cumberland WG, Sy JP. A stochastic model for analysis of longitudinal AIDS data. J Am Stat Assoc 1994; 89:727-736.
8. Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, Rinaldo CR, et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis 2000; 181:872-880.
9. Fauci AS, Pantaleo G, Stanley S, Weissman D. Immunopathogenic mechanisms of HIV infection. Ann Intern Med 1996; 124:654-663.
10. Hansen K, Chapman G, Chitsike I, Kasilo O, Mwaluko G. The costs of HIV/AIDS care at government hospitals in Zimbabwe. Health Policy Plan 2000; 15:432-440.
11. Guinness L, Arthur G, Bhatt SM, Achiya G, Kariuki S, Gilks CF. Costs of hospital care for HIV-positive and HIV-negative patients at Kenyatta National Hospital, Nairobi, Kenya. AIDS 2002; 16:901-908.
12. Hogan DR, Baltussen R, Hayashi C, Lauer JA, Salomon JA. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. Br Med J 2005; 331:1431-1437.
13. Goldie SJ, Yazdanpanah Y, Losina E, Weinstein MC, Anglaret X, Walensky RP, et al. Cost-effectiveness of HIV treatment in resource-poor settings: the case of Côte d'Ivoire. N Engl J Med 2006; 355:1141-1153.
14. Baggaley RF, Garnett GP, Ferguson NM. Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med 2006; 3:e124.
15. Bertozzi S, Bautista-Arredondo S. Modeling the impact of antiretroviral use in developing countries. PLoS Med 2006; 3:e148.
16. Koenig SP, Leandre F, Farmer PE. Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience. AIDS 2004; 18 (Suppl 3):S21-S25.
17. Paltiel AD, Weinstein MC, Kimmel AD, Seage GR III, Losina E, Zhang H, et al. Expanded screening for HIV in the United States: an analysis of cost-effectiveness. N Engl J Med 2005; 352:586-595.
18. Goldie SJ, Paltiel AD, Weinstein MC, Losina E, Seage GR III, Kimmel AD, et al. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am J Med 2003; 115:632-641.
19. Mulligan JL, Fox-Rushby J, Adam T, Johns B, Mills A. DCPP Working Paper 9: Unit Costs of Health Care Inputs in Low and Middle Income Regions. Baltimore, MD: National Institutes of Health; 2003. http://www.fic.nih.gov/dcpp/ wps/.
20. Gidwani G. Patterns of Health Care Seeking in Uganda. Baltimore: Johns Hopkins Press; 2004.
21. Uganda Bureau of Statistics. Statistical Abstract. Entebbe: Government of Uganda; 2000.